Bliss GVS Pharma Share Price
₹160.57 -2.56 (-1.57%)
22 Jan, 2025 12:16
Start SIP in BLISSGVS
Start SIPPerformance
- Low
- ₹158
- High
- ₹165
- 52 Week Low
- ₹92
- 52 Week High
- ₹186
- Open Price₹164
- Previous Close₹163
- Volume440,120
Investment Returns
- Over 1 Month -0.36%
- Over 3 Month + 21.89%
- Over 6 Month + 45.6%
- Over 1 Year + 27.23%
Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!
Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 26.7
- PEG Ratio
- -0.9
- Market Cap Cr
- 1,692
- P/B Ratio
- 1.7
- Average True Range
- 9.56
- EPS
- 7.99
- Dividend Yield
- 0.3
- MACD Signal
- 2.76
- RSI
- 49.88
- MFI
- 61.2
Bliss GVS Pharma Financials
Bliss GVS Pharma Technicals
EMA & SMA
Current Price
₹160.57
-2.56
(-1.57%)
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹164.69
- 50 Day
- ₹156.90
- 100 Day
- ₹145.77
- 200 Day
- ₹133.49
Resistance and Support
166.38
- R3 182.75
- R2 178.38
- R1 170.75
- S1 158.75
- S2 154.38
- S3 146.75
Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-10-24 | Quarterly Results | |
2024-07-24 | Quarterly Results | |
2024-05-02 | Audited Results & Final Dividend | |
2024-01-23 | Quarterly Results | |
2023-11-01 | Quarterly Results |
Bliss GVS Pharma F&O
About Bliss GVS Pharma
- NSE Symbol
- BLISSGVS
- BSE Symbol
- 506197
- Managing Director
- Mr. Gagan Harsh Sharma
- ISIN
- INE416D01022
Similar Stocks to Bliss GVS Pharma
Bliss GVS Pharma FAQs
Bliss GVS Pharma share price is ₹160 As on 22 January, 2025 | 12:02
The Market Cap of Bliss GVS Pharma is ₹1691.9 Cr As on 22 January, 2025 | 12:02
The P/E ratio of Bliss GVS Pharma is 26.7 As on 22 January, 2025 | 12:02
The PB ratio of Bliss GVS Pharma is 1.7 As on 22 January, 2025 | 12:02
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.